David A. Siegel Standard Biotools Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Standard Biotools Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 14,132 shares of LAB stock, worth $18,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,132

Previous 13,832 2.17%

Holding current value

$18,371

Previous $26,000 7.69%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.5 - $2.26 $450 - $677	300 Added 2.17%	14,132 $24,000
Q3 2024 Nov 14, 2024	SELL	$1.42 - $2.35 $34,932 - $57,810	-24,600 Reduced 64.01%	13,832 $26,000
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $50,849 - $89,988	-30,818 Reduced 44.5%	38,432 $68,000
Q1 2024 May 15, 2024	SELL	$1.87 - $2.78 $3,811 - $5,665	-2,038 Reduced 2.86%	69,250 $187,000
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $81,706 - $140,289	51,388 Added 258.23%	71,288 $157,000
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.05 $19,380 - $31,110	-10,200 Reduced 33.89%	19,900 $57,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $5,439 - $9,472	-3,700 Reduced 10.95%	30,100 $58,000
Q1 2023 May 15, 2023	SELL	$1.3 - $2.24 $6,760 - $11,648	-5,200 Reduced 13.33%	33,800 $65,000
Q4 2022 Feb 14, 2023	SELL	$0.93 - $1.52 $33,108 - $54,112	-35,600 Reduced 47.72%	39,000 $45,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $2.06 $880 - $1,648	800 Added 1.08%	74,600 $82,000
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $5,600 - $13,965	3,500 Added 4.98%	73,800 $118,000
Q1 2022 May 16, 2022	BUY	$2.8 - $3.96 $10,080 - $14,256	3,600 Added 5.4%	70,300 $252,000
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $342,991 - $579,211	-94,488 Reduced 58.62%	66,700 $261,000
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $138,600 - $186,732	-25,200 Reduced 13.52%	161,188 $1.06 Million
Q2 2021 Aug 16, 2021	SELL	$4.35 - $6.35 $2.11 Million - $3.08 Million	-485,100 Reduced 72.24%	186,388 $1.15 Million
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $783,272 - $1.41 Million	-198,800 Reduced 22.84%	671,488 $3.04 Million
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $3.18 Million - $5.05 Million	584,274 Added 204.28%	870,288 $5.22 Million
Q3 2020 Nov 16, 2020	SELL	$4.34 - $11.43 $2.9 Million - $7.63 Million	-667,874 Reduced 70.02%	286,014 $2.13 Million
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $31,080 - $88,872	16,800 Added 1.79%	953,888 $3.83 Million
Q1 2020 May 15, 2020	SELL	$1.24 - $4.35 $14,136 - $49,589	-11,400 Reduced 1.2%	937,088 $2.38 Million
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $198,719 - $442,368	86,400 Added 10.02%	948,488 $3.3 Million
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $442,165 - $1.16 Million	95,500 Added 12.46%	862,088 $3.99 Million
Q2 2019 Aug 14, 2019	SELL	$11.49 - $14.17 $99,963 - $123,279	-8,700 Reduced 1.12%	766,588 $9.44 Million
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $3.45 Million - $5.85 Million	407,600 Added 110.85%	775,288 $10.3 Million
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $1.78 Million - $2.19 Million	247,600 Added 206.18%	367,688 $3.17 Million
Q3 2018 Nov 14, 2018	BUY	$5.92 - $8.35 $232,656 - $328,155	39,300 Added 48.65%	120,088 $899,000
Q2 2018 Aug 14, 2018	BUY	$4.86 - $6.24 $121,986 - $156,624	25,100 Added 45.07%	80,788 $481,000
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $228,781 - $317,110	39,788 Added 250.24%	55,688 $325,000
Q4 2017 Feb 14, 2018	BUY	$4.46 - $6.45 $16,948 - $24,510	3,800 Added 31.4%	15,900 $94,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $42,955 - $66,429	12,100	12,100 $61,000

Others Institutions Holding LAB

# of Institutions

143

Shares Held

274M

Call Options Held

6.7K

Put Options Held

48.7K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $102M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account